16 results
·
44ms
·
Sources: EU EUDAMED, US FDA
Filters
FDA Classification
×
Electromechanical System For Open Microsurgery
FDA classification
FDA Class 2
·Electromechanical System For Open Microsurgery
Bag, Urine Collection, Leg, For External Use, Non-Sterile
FDA classification
FDA Class 1
·Bag, Urine Collection, Leg, For External Use, Non-Sterile
Sensor, Pressure, Aneurysm, Implantable
FDA classification
FDA Class 2
·Sensor, Pressure, Aneurysm, Implantable
Pipette, Sahli
FDA classification
FDA Class 1
·Pipette, Sahli
Rongeur, Lachrymal Sac
FDA classification
FDA Class 1
·Rongeur, Lachrymal Sac
Igg (Fd Fragment Specific), Antigen, Antiserum, Control
FDA classification
FDA Class 1
·Igg (Fd Fragment Specific), Antigen, Antiserum, Control
Detector, Ultraviolet
FDA classification
FDA Class 2
·Detector, Ultraviolet
Sars-Cov-2 Serology Test
FDA classification
FDA Class 2
·Sars-Cov-2 Serology Test
Suture, Nonabsorbable, Steel, Monofilament And Multifilament, Sterile, Exempt
FDA classification
FDA Class 2
·Suture, Nonabsorbable, Steel, Monofilament And Multifilament, Sterile, Exempt
Non-Sars Coronavirus Multiplex Nucleic Acid Assay
FDA classification
FDA Class 2
·Non-Sars Coronavirus Multiplex Nucleic Acid Assay
Respiratory Specimen Nucleic Acid Sars-Cov-2 Test
FDA classification
FDA Class 2
·Respiratory Specimen Nucleic Acid Sars-Cov-2 Test
Ngs Whole Genome Sequencing For Sars-Cov-2 Genetic Analysis
FDA classification
FDA Not Classified
·Ngs Whole Genome Sequencing For Sars-Cov-2 Genetic Analysis
Over-The-Counter Molecular Test To Detect Sars-Cov-2 From Clinical Specimens
FDA classification
FDA Class 2
·Over-The-Counter Molecular Test To Detect Sars-Cov-2 From Clinical Specimens
Multi-Target Respiratory Specimen Nucleic Acid Test Including Sars-Cov-2 And Other Microbial Agents
FDA classification
FDA Class 2
·Multi-Target Respiratory Specimen Nucleic Acid Test Including Sars-Cov-2 And Other Microbial Agents
Simple Point-Of-Care Device To Directly Detect Sars-Cov-2 Viral Targets From Clinical Specimens In Near-Patient Settings
FDA classification
FDA Class 2
·Simple Point-Of-Care Device To Directly Detect Sars-Cov-2 Viral Targets From Clinical Specimens In Near-Patient Settings
Simple Point-Of-Care Device To Detect Sar-Cov-2 Nucleic Acid Targets From Clinical Specimens In Near-Patient Settings
FDA classification
FDA Class 2
·Simple Point-Of-Care Device To Detect Sar-Cov-2 Nucleic Acid Targets From Clinical Specimens In Near-Patient Settings